Lung AI vs Vivid T8

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Lung AI

by Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)

Vivid T8

by GE HealthCare

AI Verdict

Tool A is a handheld, AI-integrated ultrasound device designed for point-of-care diagnostics in lung and cardiac conditions, featuring on-device AI for real-time assistance. In contrast, Tool B is a console-based, comprehensive cardiovascular ultrasound system that incorporates AI primarily for workflow efficiency in a broader clinical setting. While both leverage AI in ultrasound, their deployment models and the specific applications of their AI capabilities cater to distinct clinical needs and environments.

Choose Lung AI if…

Choose Lung AI if your clinical setting demands highly portable, immediate diagnostic capabilities for lung and basic cardiac conditions at the point of care. Its on-device AI and guided image capture are ideal for rapid assessments in emergency medicine, critical care, or remote environments where quick, AI-powered insights are crucial and internet connectivity may be limited.

View Lung AI →

Choose Vivid T8 if…

Choose the Vivid T8 if your practice requires a robust, console-based ultrasound system for comprehensive cardiovascular diagnostics and shared-service applications. Its advanced quantitative tools and multiple transducer ports are well-suited for detailed cardiac assessments, stress echocardiography, and a wide range of general imaging needs within a fixed clinical environment.

View Vivid T8 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Lung AI	Vivid T8
Pricing	Unknown	Contact vendor
Deployment	Cloud-based, integrated with existing platforms (e.g., RapidAI), and potentially on-premise.	On-premise (console-based medical device)
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung AI

Tool A, Lung AI, is a handheld device explicitly designed for ease of use with features like guided image capture and real-time feedback, making it highly accessible for point-of-care applications. Its dedicated training platform, Exo U, further enhances user proficiency. While Tool B is designed for ease of use within its console category, Tool A's portability and specific usability features provide a distinct advantage.

Clinical Value

Lung AI

Tool A offers direct AI-powered diagnostic assistance for critical conditions such as pleural effusion, consolidation/atelectasis, and automated indicators for cardiac conditions, directly aiding clinical decision-making at the point of care. Tool B, while providing advanced quantitative tools for comprehensive cardiac assessment, primarily focuses its AI capabilities on workflow efficiency rather than direct diagnostic detection.

Pricing & Value

Vivid T8

Tool B provides greater pricing transparency by offering a starting price for refurbished units and explicitly includes three years of service coverage, which adds significant long-term value. Tool A, despite being described as 'affordable,' does not provide any specific pricing details, making it difficult to assess its comparative value.

Enterprise Readiness

Lung AI

Tool A explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), crucial for healthcare data handling. Its on-device AI processing, operating without an internet connection, further enhances security and reliability for enterprise deployment. Tool B's HIPAA statement is more about the user's responsibility, and no BAA is mentioned, giving Tool A an edge in explicit enterprise compliance and security features.

Innovation

Lung AI

Tool A represents a more significant innovation by integrating advanced, real-time, diagnostic AI directly into a high-performance, handheld ultrasound platform for specific diagnostic detection. This combination of portability and direct AI-powered diagnosis is pioneering for point-of-care. Tool B's AI features are primarily focused on workflow efficiency, which, while valuable, is less groundbreaking than Tool A's approach to diagnostic AI.

Support & Docs

Vivid T8

Tool B explicitly includes three years of service coverage, providing a clear and substantial commitment to ongoing support and maintenance, which is vital for medical devices in an enterprise setting. While Tool A offers valuable education and training through 'Exo U' and customer support contacts, it does not specify comparable long-term service agreements.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Lung AI	Vivid T8
Product Name	Lung AI	Vivid T8
Company	Exo	GE HealthCare
Primary Application/Description	Handheld ultrasound platform that uses artificial intelligence for imaging and therapeutic applications, focusing on cardiac and lung scanning.	Hybrid cardiovascular ultrasound system offering advanced imaging capabilities for cardiac and shared services, designed for reliability and ease of use, with AI-based tools for workflow efficiency in its Ultra Edition.
Key AI Capabilities	AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis, real-time feedback and image quality monitoring (SweepAI), automated AI-based indicators for cardiac conditions, guided image capture for optimal scans, on-device AI processing (operates without internet).	AI-based tools for workflow efficiency (Vivid T8 Ultra Edition).
Form Factor / Hardware Details	High-performance, handheld ultrasound platform; Pulsed-wave Doppler capabilities (on Exo Iris).	Console-based medical device; 19-inch LCD monitor (21.5-inch for Ultra Edition) and 8.4-inch LCD touchscreen (10.1-inch multi-touch for Ultra Edition); 4 active transducer ports; rugged, durable, and mobile design.

Videos

Demos, reviews, and walkthroughs featuring Lung AI and Vivid T8.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for different specialties, particularly regarding point-of-care versus comprehensive studies?

Lung AI, with its handheld design and on-device AI for lung and cardiac conditions, is optimized for rapid, real-time point-of-care decisions in emergency medicine or pulmonology. The Vivid T8, as a console-based hybrid system with advanced quantitative tools, is better suited for comprehensive cardiovascular and shared-service studies in dedicated cardiology or radiology departments.

Beyond the listed specialties, what specific clinical scenarios or patient populations are each tool best suited for, given their AI capabilities and design?

Lung AI excels in scenarios requiring immediate assessment of conditions like pleural effusion or consolidation/atelectasis, and for rapid cardiac indicators, making it valuable in critical care or remote settings. The Vivid T8, with its robust quantitative cardiac tools and shared-service capabilities, is ideal for detailed diagnostic evaluations, stress echocardiography, and follow-up for complex cardiovascular patients.

What kind of training and support is available to ensure proficiency with the AI features and advanced functionalities of each system?

Lung AI offers 'Exo U,' an AI-powered POCUS education and training platform, alongside guided image capture, suggesting a streamlined learning curve for point-of-care users. The Vivid T8, while designed for ease of use, includes advanced quantitative tools that may require more in-depth training, typically provided by GE HealthCare, to maximize its comprehensive diagnostic capabilities.

What are the capabilities for integrating imaging data and AI analysis results into the electronic health record (EHR), and what audit-trail features are available?

The Vivid T8 supports DICOM and EchoPAC compatibility, facilitating standard integration with PACS and EHR systems for image analysis and sharing, likely including audit trails for studies. Lung AI's 'Exo Works' platform allows for seamless documentation, QA, and billing, with options to send and store exams to PACS, VNA, or EHR via DICOM or local network storage, and offers multi-factor authentication for security.

Can you elaborate on the diagnostic accuracy and sensitivity of the AI-powered detection features for specific conditions?

Lung AI explicitly offers AI-powered detection for pleural effusion, consolidation/atelectasis, and automated indicators for cardiac conditions like heart failure and hypertrophy, with studies showing significant increases in sensitivity for lung conditions. The Vivid T8 Ultra Edition features AI-based tools primarily for workflow efficiency, such as AI Auto Measure 2D and Cardiac Auto Doppler, which aim to reduce manual steps and improve reproducibility rather than providing specific diagnostic detections.

For a multi-site healthcare system, what are the key considerations for deploying these systems across different locations?

Lung AI's handheld, on-device processing nature makes it potentially easier to deploy and scale across multiple sites, especially for point-of-care applications, without extensive network infrastructure for AI processing. The console-based Vivid T8, while mobile and rugged, would require more traditional medical device deployment planning, including physical space, power, and network connectivity for its DICOM capabilities at each site.